Amedeo Smart

Free Medical Literature Service


 

Amedeo

Colorectal Neoplasms

  Free Subscription

Articles published in
Br J Surg
    July 2021
  1. EBBEHOJ AL, Jorgensen LN, Krarup PM, Smith HG, et al
    Histopathological risk factors for lymph node metastases in T1 colorectal cancer: meta-analysis.
    Br J Surg. 2021 Jul 9. pii: 6304963. doi: 10.1093.
    >> Share

    June 2021
  2. SPYCHALSKI M, Wlodarczyk M, Winter K
    Impact of COVID-19 pandemic on endoscopic submucosal dissection outcomes in early colorectal tumours.
    Br J Surg. 2021;108:e224-e225.
    >> Share

  3. GONELLA F, Massucco P, Perotti S, Monasterolo S, et al
    Telemedicine prehabilitation as a result of COVID-19: disruptive technological solutions.
    Br J Surg. 2021;108:e215-e216.
    >> Share

    May 2021
  4. DE HINGH IHJT
    Heated intraperitoneal chemotherapy for colorectal cancer: game over or game on?
    Br J Surg. 2021 May 10. pii: 6273040. doi: 10.1093.
    >> Share

    April 2021
  5. DONG DZ, Dong QS, Zhang FN, Li CL, et al
    Impact of COVID-19 on treatment modalities and short-term outcomes of rectal cancer following neoadjuvant chemoradiotherapy: a retrospective study.
    Br J Surg. 2021;108:e164-e165.
    >> Share

  6. ABDELLATIF M, Salama Y, Alhammali T, Eltweri AM, et al
    Impact of COVID-19 on colorectal cancer early diagnosis pathway: retrospective cohort study.
    Br J Surg. 2021 Apr 1. pii: 6207608. doi: 10.1093.
    >> Share

    March 2021
  7. AGUIAR S, Riechelmann RP, de Mello CAL, da Silva JCF, et al
    Impact of COVID-19 on colorectal cancer presentation.
    Br J Surg. 2021;108:e81-e82.
    >> Share

  8. WANG X, Zheng Z, Yu Q, Huang Y, et al
    Do young patients with rectal cancer have outcomes comparable to those of their older counterparts? A statistical problem and countermeasure.
    Br J Surg. 2021;108:e83.
    >> Share

  9. SCHAAP DP, Boogerd LSF, Konishi T, Cunningham C, et al
    Rectal cancer lateral lymph nodes: multicentre study of the impact of obturator and internal iliac nodes on oncological outcomes.
    Br J Surg. 2021;108:205-213.
    >> Share

  10. FLEMING CA, Cullinane C, Lynch N, Killeen S, et al
    Urogenital function following robotic and laparoscopic rectal cancer surgery: meta-analysis.
    Br J Surg. 2021;108:128-137.
    >> Share

  11. LAU S, Kong J, Bell S, Heriot A, et al
    Transanal mesorectal excision: early outcomes in Australia and New Zealand.
    Br J Surg. 2021;108:214-219.
    >> Share

    January 2021
  12. ABDULKARIM A, Barasa M
    Clinicopathological profile of colorectal cancer at a tertiary hospital in Kenya.
    Br J Surg. 2021 Jan 31. pii: 6124826. doi: 10.1093.
    >> Share

  13. HABIB BEDWANI N, English W, Coda S, Akinlade F, et al
    Developing a prioritization model for endoscopy and colorectal cancer 2-week wait referrals during the COVID-19 pandemic-is faecal immunochemical testing the answer?
    Br J Surg. 2021;108:e18-e19.
    >> Share

  14. CAHILL RA, O'Shea DF, Khan MF, Khokhar HA, et al
    Artificial intelligence indocyanine green (ICG) perfusion for colorectal cancer intra-operative tissue classification.
    Br J Surg. 2021;108:5-9.
    >> Share

  15. ROCKALL TA
    Transanal total mesorectal excision: the race to the bottom.
    Br J Surg. 2021;108:3-4.
    >> Share

  16. ROUANET P, Rivoire M, Gourgou S, Lelong B, et al
    Sphincter-saving surgery after neoadjuvant therapy for ultra-low rectal cancer where abdominoperineal resection was indicated: 10-year results of the GRECCAR 1 trial.
    Br J Surg. 2021;108:10-13.
    >> Share

  17. TOLLEY T, Whewell H, Davies DR, Codd RJ, et al
    Colorectal cancer referrals during the COVID-19 pandemic: the utility of CT and faecal immunochemical testing.
    Br J Surg. 2021 Jan 25. pii: 6120047. doi: 10.1093.
    >> Share

  18. YOKOYAMA S, Fujita Y, Matsumura S, Yoshimura T, et al
    Cribriform carcinoma in the lymph nodes is associated with distant metastasis, recurrence, and survival among patients with node-positive colorectal cancer.
    Br J Surg. 2021 Jan 11. pii: 6082763. doi: 10.1093.
    >> Share

    December 2020
  19. HEALEY BIRD BRJ
    Total neoadjuvant therapy for locally advanced rectal cancer: the fuse is lit.
    Br J Surg. 2020;107:1705-1707.
    >> Share

  20. VAN OOSTENDORP SE, Smits LJH, Vroom Y, Detering R, et al
    Local recurrence after local excision of early rectal cancer: a meta-analysis of completion TME, adjuvant (chemo)radiation, or no additional treatment.
    Br J Surg. 2020;107:1719-1730.
    >> Share

  21. DENOST Q, Solomon M, Tuech JJ, Ghouti L, et al
    International variation in managing locally advanced or recurrent rectal cancer: prospective benchmark analysis.
    Br J Surg. 2020;107:1846-1854.
    >> Share

  22. LIGHTNER AL, Vaidya P, Vogler S, McMichael J, et al
    Surveillance pouchoscopy for dysplasia: Cleveland Clinic Ileoanal Pouch Anastomosis Database.
    Br J Surg. 2020;107:1826-1831.
    >> Share

  23. JORGREN F, Lydrup ML, Buchwald P
    Impact of rectal perforation on recurrence during rectal cancer surgery in a national population registry.
    Br J Surg. 2020;107:1818-1825.
    >> Share

    November 2020
  24. MARCHEGIANI F, Barina A, Spolverato G, Pucciarelli S, et al
    Defunctioning stoma in young patients affected by rectal cancer: a delicate balance.
    Br J Surg. 2020;107:e639.
    >> Share

  25. HIDAYAT H, Etherson K, Shanmugam V
    Comment on: Short-term outcomes of a multicentre randomized clinical trial comparing D2 versus D3 lymph node dissection for colonic cancer (COLD trial).
    Br J Surg. 2020;107:e627.
    >> Share

  26. PETROV A
    Author response to: Comment on: Short-term outcomes of a multicentre randomized clinical trial comparing D2 versus D3 lymph node dissection for colonic cancer (COLD trial).
    Br J Surg. 2020;107:e628.
    >> Share

  27. JORGREN F, Lydrup ML, Buchwald P
    Author response to: Comment on: Impact of rectal perforation on recurrence during rectal cancer surgery in a national population registry.
    Br J Surg. 2020;107:e622.
    >> Share

  28. WU Q, Jin Z, Peng Y, Wang Z, et al
    Comment on: Impact of rectal perforation on recurrence during rectal cancer surgery in a national population registry.
    Br J Surg. 2020;107:e621.
    >> Share

  29. TUYNMAN JB, van Oostendorp SE, Kusters M, Sietses C, et al
    Author response to: TaTME and the worse oncological outcome - new data demonstrates a difficult method.
    Br J Surg. 2020;107:e612.
    >> Share

  30. WASMUTH HH, Larsen SG, Faerden AE
    TaTME and the worse oncological outcome - new data demonstrates a difficult method.
    Br J Surg. 2020;107:e611.
    >> Share

  31. PEACOCK O, Limvorapitak T, Hu CY, Bednarski BK, et al
    Robotic rectal cancer surgery: comparative study of the impact of obesity on early outcomes.
    Br J Surg. 2020;107:1552-1557.
    >> Share

  32. WILLIAMSON JS, Quyn AJ, Sagar PM
    Rectal cancer lateral pelvic sidewall lymph nodes: a review of controversies and management.
    Br J Surg. 2020;107:1562-1569.
    >> Share

    October 2020
  33. HUDDY JR, Freeman Z, Crockett M, Hadjievangelou N, et al
    Establishing a "cold" elective unit for robotic colorectal and urological cancer surgery and regional vascular surgery following the initial COVID-19 surge.
    Br J Surg. 2020;107:e466-e467.
    >> Share


  34. The impact of the COVID-19 pandemic on the Management of Locally Advanced Primary/Recurrent Rectal Cancer.
    Br J Surg. 2020;107:e547-e548.
    >> Share

  35. ZHOU X, Liu Z, Zhang D, Wu L, et al
    Improving initial nodal staging of T3 rectal cancer using quantitative image features.
    Br J Surg. 2020;107:e541-e542.
    >> Share

  36. EFETOV SK, Lychagin AV, Zubayraeva AA, Picciariello A, et al
    3D-printed pubic bone for pelvic ring reconstruction after exenteration for anal cancer recurrence.
    Br J Surg. 2020;107:e512-e514.
    >> Share

    September 2020
  37. MA J, Whittaker Y, Chandran P
    Male Sexual Dysfunction after Pelvic Surgery for Colorectal Cancer.
    Br J Surg. 2020 Sep 8. doi: 10.1002/bjs.12033.
    >> Share

  38. LIYANAGE ASD, Gokul K, Babu BH, Ainsworth P, et al
    Stage migration of colorectal cancer during COVID-19 pandemic.
    Br J Surg. 2020 Sep 2. doi: 10.1002/bjs.11936.
    >> Share

  39. BARRETT K, Habib Bedwani N, Arya S, Bhargava A, et al
    Colorectal cancer referrals during the COVID-19 pandemic - a model for the faster diagnosis standard?
    Br J Surg. 2020 Sep 1. doi: 10.1002/bjs.12008.
    >> Share

  40. DETERING R, van Oostendorp SE, Meyer VM, van Dieren S, et al
    MRI cT1-2 rectal cancer staging accuracy: a population-based study.
    Br J Surg. 2020;107:1372-1382.
    >> Share

  41. SAKAMOTO T, Fujiogi M, Lefor AK, Matsui H, et al
    Stent as a bridge to surgery or immediate colectomy for malignant right colonic obstruction: propensity-scored, national database study.
    Br J Surg. 2020;107:1354-1362.
    >> Share

    August 2020
  42. KONTOVOUNISIOS C
    The impact of the COVID-19 pandemic on colorectal cancer service provision.
    Br J Surg. 2020 Aug 28. doi: 10.1002/bjs.11990.
    >> Share

  43. BEHM KT, Grass F, Abd El Aziz MA, Kelley SR, et al
    Short term oncological outcomes of completely intracorporeal anastomosis after left sided robotic resections for colorectal cancer.
    Br J Surg. 2020 Aug 26. doi: 10.1002/bjs.11955.
    >> Share

  44. TREASURE T, Leonard P, Milosevic M, Williams NR, et al
    Pulmonary Metastasectomy in Colorectal Cancer: the PulMiCC randomised controlled trial.
    Br J Surg. 2020 Aug 21. doi: 10.1002/bjs.11948.
    >> Share

  45. DARVISH-DAMAVANDI M, Laycock J, Ward C, van Driel MS, et al
    An analysis of SARS-CoV-2 cell entry genes identifies the intestine and colorectal cancer as susceptible tissues.
    Br J Surg. 2020 Aug 10. doi: 10.1002/bjs.11911.
    >> Share

  46. MOHAMED F, Kallioinen M, Braun M, Fenwick S, et al
    Author response to: NICE Guidelines: management of colorectal cancer metastases.
    Br J Surg. 2020;107:e358.
    >> Share

  47. MARINO F, Trompetto M, Gallo G
    COVID-19 pandemic: a large boulder on the head of stoma patients.
    Br J Surg. 2020;107:e303.
    >> Share

  48. WARRIER SK, Bell S, Guest G, Heriot A, et al
    Locoregional recurrences after transanal total mesorectal excision of rectal cancer during the exploration phase.
    Br J Surg. 2020;107:e353.
    >> Share

  49. BERGAMASCHI R, Gachabayov M, Orangio G, Remzi F, et al
    Evidence supporting the sunk cost fallacy of advocating for transanal total mesorectal excision.
    Br J Surg. 2020;107:e347.
    >> Share

  50. VAN OOSTENDORP SE, Sietses C, Hompes R, Kusters M, et al
    Author response to: Evidence supporting the sunk cost fallacy of advocating for transanal total mesorectal excision.
    Br J Surg. 2020;107:e348.
    >> Share

  51. VAN OOSTENDORP SE, Belgers HJ, Bootsma BT, Hol JC, et al
    Locoregional recurrences after transanal total mesorectal excision of rectal cancer during implementation.
    Br J Surg. 2020;107:1211-1220.
    >> Share

    July 2020
  52. CARRANO FM, Foppa C, Carvello M, Spinelli A, et al
    With adequate precautions colorectal cancer surgery can be safely continued during COVID-19 pandemic.
    Br J Surg. 2020 Jul 31. doi: 10.1002/bjs.11859.
    >> Share

  53. CHAN DKH, Keh CHL, Seow CS, Iau PTC, et al
    Maintaining quality of care in colorectal cancer surgery during the COVID-19 pandemic.
    Br J Surg. 2020 Jul 31. doi: 10.1002/bjs.11866.
    >> Share

  54. MAEDA Y, Dunlop MG, Din FVN
    Risk mitigation for suspected colorectal cancer diagnostic pathway during COVID-19 pandemic.
    Br J Surg. 2020 Jul 23. doi: 10.1002/bjs.11798.
    >> Share

  55. BAUM M, Fallowfield L, Farewell V, Macbeth F, et al
    NICE Guidelines: management of colorectal cancer metastases.
    Br J Surg. 2020 Jul 11. doi: 10.1002/bjs.11789.
    >> Share

  56. MIRNEZAMI R, Knowles J, Kar A, Glynne-Jones R, et al
    Preoperative radiotherapy for locally advanced rectal cancer during and after the COVID-19 pandemic.
    Br J Surg. 2020;107:e263.
    >> Share

  57. GIANI I, Elbetti C, Trompetto M, Gallo G, et al
    Proctology in the COVID-19 era: handle with care.
    Br J Surg. 2020;107:e243.
    >> Share

  58. TSUKAMOTO S, Fujita S, Kanemitsu Y
    Author response to: Beyond T, N and M: can lateral lymph node dissection treat tumour deposits in advanced low rectal carcinoma?
    Br J Surg. 2020;107:e291.
    >> Share

  59. PEPARINI N
    Beyond T, N and M: can lateral lymph node dissection treat tumour deposits in advanced low rectal carcinoma?
    Br J Surg. 2020;107:e290.
    >> Share

  60. PEREA J, Garcia JL, Garcia-Olmo D, Urioste M, et al
    Comment on: Clinicopathological features and oncological outcomes of patients with young-onset rectal cancer.
    Br J Surg. 2020;107:e277.
    >> Share

    June 2020
  61. TUTTON MG
    Colorectal cancer surgery during the COVID-19 pandemic.
    Br J Surg. 2020 Jun 3. doi: 10.1002/bjs.11734.
    >> Share

  62. D'SOUZA N, Abulafi M
    Navigating the storm of COVID-19 for patients with suspected bowel cancer.
    Br J Surg. 2020;107:e204.
    >> Share

  63. LACY AM, De Lacy FB, Balibrea JM
    Considerations for transanal total mesorectal excision (TaTME) use during the COVID-19 pandemic.
    Br J Surg. 2020;107:e203.
    >> Share

  64. WARRIER SK, Bell S, Kong JC, Larach T, et al
    Comments on: Transanal total mesorectal excision for rectal cancer has been suspended in Norway.
    Br J Surg. 2020;107:e221.
    >> Share

  65. LARSEN SG, Faerden AE, Wasmuth HH
    Author response to: Comment on: Transanal total mesorectal excision for rectal cancer has been abandoned in Norway.
    Br J Surg. 2020;107:e222.
    >> Share

  66. WASMUTH HH, Faerden AE, Larsen SG
    Author response to: Comment on: Transanal total mesorectal excision for rectal cancer has been abandoned in Norway.
    Br J Surg. 2020;107:e224.
    >> Share

  67. SEOW-EN I, Seow-Choen F
    Comment on: Transanal total mesorectal excision for rectal cancer has been abandoned in Norway.
    Br J Surg. 2020;107:e223.
    >> Share

  68. CRIPPA J, Grass F, Larson DW
    Author response to: Is robotic approach associated with a lower risk of conversion in rectal cancer surgery compared with laparoscopic approach?
    Br J Surg. 2020;107:e227.
    >> Share

  69. YANG TH, Shen Y
    Comment on: Risk factors for conversion in laparoscopic and robotic rectal cancer surgery.
    Br J Surg. 2020;107:e225.
    >> Share

  70. JIA HD, Diao YK, Li C, Liang L, et al
    Is robotic approach associated with a lower risk of conversion in rectal cancer surgery compared with laparoscopic approach?
    Br J Surg. 2020;107:e226.
    >> Share

  71. SOCHA J, Bujko K
    Should a minimum 8-week interval between preoperative radiotherapy and surgery become the standard of care? No, it shouldn't.
    Br J Surg. 2020;107:e211-e212.
    >> Share

  72. RYAN EJ, O'Riordan JM, Winter DC
    Author response to: Should a minimum 8-week interval between preoperative radiotherapy and surgery become the standard of care? No, it shouldn't.
    Br J Surg. 2020;107:e213-e214.
    >> Share

    May 2020
  73. ALTAF K, Tan J, Parvaiz A, Ahmed S, et al
    Impact on colorectal cancer in COVID-19 pandemic.
    Br J Surg. 2020 May 29. doi: 10.1002/bjs.11720.
    >> Share


  74. Colorectal cancer services during the COVID-19 pandemic.
    Br J Surg. 2020 May 22. doi: 10.1002/bjs.11706.
    >> Share

  75. MOHAMED F, Kallioinen M, Braun M, Fenwick S, et al
    Management of colorectal cancer metastases to the liver, lung or peritoneum suitable for curative intent: summary of NICE guidance.
    Br J Surg. 2020 May 9. doi: 10.1002/bjs.11609.
    >> Share

  76. DIAO YK, Liang L, Li C, Zhang CW, et al
    Is there a causal relationship between blood cultures after surgery for colorectal cancer and long-term oncological outcomes?
    Br J Surg. 2020;107:773.
    >> Share

    April 2020
  77. CULLINANE CM, Creavin B, O'Connell EP, Kelly L, et al
    Risk of colorectal cancer associated with BRCA1 and/or BRCA2 mutation carriers: systematic review and meta-analysis.
    Br J Surg. 2020 Apr 16. doi: 10.1002/bjs.11603.
    >> Share

  78. KATAOKA K, Beppu N, Shiozawa M, Ikeda M, et al
    Colorectal cancer treated by resection and extended lymphadenectomy: patterns of spread in left- and right-sided tumours.
    Br J Surg. 2020 Apr 4. doi: 10.1002/bjs.11517.
    >> Share

  79. DENOST Q
    The challenge posed by young-onset rectal cancer.
    Br J Surg. 2020;107:481-483.
    >> Share

  80. TSUKAMOTO S, Fujita S, Ota M, Mizusawa J, et al
    Long-term follow-up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer (JCOG0212).
    Br J Surg. 2020;107:586-594.
    >> Share

  81. VAN DER HEIJDEN JAG, Koeter T, Smits LJH, Sietses C, et al
    Functional complaints and quality of life after transanal total mesorectal excision: a meta-analysis.
    Br J Surg. 2020;107:489-498.
    >> Share

  82. NG KS, Russo R, Gladman MA
    Colonic transit in patients after anterior resection: prospective, comparative study using single-photon emission CT/CT scintigraphy.
    Br J Surg. 2020;107:567-579.
    >> Share

  83. ZABOROWSKI AM, Murphy B, Creavin B, Rogers AC, et al
    Clinicopathological features and oncological outcomes of patients with young-onset rectal cancer.
    Br J Surg. 2020;107:606-612.
    >> Share

  84. AGGER EA, Jorgren FH, Lydrup MA, Buchwald PL, et al
    Risk of local recurrence of rectal cancer and circumferential resection margin: population-based cohort study.
    Br J Surg. 2020;107:580-585.
    >> Share

  85. KOK END, Havenga K, Tanis PJ, de Wilt JHW, et al
    Multicentre study of short-course radiotherapy, systemic therapy and resection/ablation for stage IV rectal cancer.
    Br J Surg. 2020;107:537-545.
    >> Share

  86. CRIPPA J, Grass F, Achilli P, Mathis KL, et al
    Risk factors for conversion in laparoscopic and robotic rectal cancer surgery.
    Br J Surg. 2020;107:560-566.
    >> Share

  87. GRASS F, Hubner M, Mathis KL, Hahnloser D, et al
    Identification of patients eligible for discharge within 48 h of colorectal resection.
    Br J Surg. 2020;107:546-551.
    >> Share

  88. KARACHUN A, Panaiotti L, Chernikovskiy I, Achkasov S, et al
    Short-term outcomes of a multicentre randomized clinical trial comparing D2 versus D3 lymph node dissection for colonic cancer (COLD trial).
    Br J Surg. 2020;107:499-508.
    >> Share

  89. SVANSTROM ROJVALL A, Buchli C, Bottai M, Ahlberg M, et al
    Effect of radiotherapy for rectal cancer on female sexual function: a prospective cohort study.
    Br J Surg. 2020;107:525-536.
    >> Share

    March 2020
  90. CHAMBERS AC, Dixon SW, White P, Williams AC, et al
    Demographic trends in the incidence of young-onset colorectal cancer: a population-based study.
    Br J Surg. 2020 Mar 9. doi: 10.1002/bjs.11486.
    >> Share

  91. RONCATI L, Manenti A, ZIzzo M, Farinetti A, et al
    Comment on: Prognosis of patients with colonic carcinoma before, during and after implementation of complete mesocolic excision.
    Br J Surg. 2020;107:464.
    >> Share

  92. MERKEL S, Hohenberger W
    Author response to: Comment on: Prognosis of patients with colonic carcinoma before, during and after implementation of complete mesocolic excision.
    Br J Surg. 2020;107:464.
    >> Share

    February 2020
  93. KOBAYASHI M, Kako J, Kajiwara K, Oosono Y, et al
    Comment on: Predicting return to work among patients with colorectal cancer.
    Br J Surg. 2020;107:318.
    >> Share

    January 2020
  94. ALMAZEEDI S, El-Abd R, Al-Khamis A, Albatineh AN, et al
    Role of bariatric surgery in reducing the risk of colorectal cancer: a meta-analysis.
    Br J Surg. 2020 Jan 24. doi: 10.1002/bjs.11494.
    >> Share

  95. SCHAAP DP, de Valk KS, Deken MM, Meijer RPJ, et al
    Carcinoembryonic antigen-specific, fluorescent image-guided cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer.
    Br J Surg. 2020 Jan 21. doi: 10.1002/bjs.11523.
    >> Share

  96. SARASTE D, Jaras J, Martling A
    Population-based analysis of outcomes with early-age colorectal cancer.
    Br J Surg. 2020 Jan 10. doi: 10.1002/bjs.11333.
    >> Share

  97. XU YJ, Sun X, Jiang H, Yin YH, et al
    Randomized clinical trial of continuous transversus abdominis plane block, epidural or patient-controlled analgesia for patients undergoing laparoscopic colorectal cancer surgery.
    Br J Surg. 2020;107:e133-e141.
    >> Share

  98. RYAN EJ, O'Riordan JM, Winter DC
    Author response to: Comment on: Meta-analysis of the effect of extending the interval after long-course chemoradiotherapy before surgery in locally advanced rectal cancer.
    Br J Surg. 2020;107:151-152.
    >> Share

  99. HAJIBANDEH S, Hajibandeh S
    Comment on: Meta-analysis of the effect of extending the interval after long-course chemoradiotherapy before surgery in locally advanced rectal cancer.
    Br J Surg. 2020;107:151.
    >> Share

  100. WASMUTH HH, Faerden AE, Myklebust TA, Pfeffer F, et al
    Transanal total mesorectal excision for rectal cancer has been suspended in Norway.
    Br J Surg. 2020;107:121-130.
    >> Share

  101. VAN DER SLUIS FJ, Couwenberg AM, de Bock GH, Intven MPW, et al
    Population-based study of morbidity risk associated with pathological complete response after chemoradiotherapy for rectal cancer.
    Br J Surg. 2020;107:131-139.
    >> Share

    December 2019
  102. LARSEN SG, Pfeffer F, Korner H
    Author response to: Comments on: Norwegian moratorium on transanal total mesorectal excision.
    Br J Surg. 2019;106:1855.
    >> Share

  103. LACY AM, Nogueira ST, de Lacy FB
    Comment on: Norwegian moratorium on transanal total mesorectal excision.
    Br J Surg. 2019;106:1855.
    >> Share

    November 2019
  104. WATT SK, Fransgaard T, Degett TH, Thygesen LC, et al
    Associations between blood cultures after surgery for colorectal cancer and long-term oncological outcomes.
    Br J Surg. 2019 Nov 22. doi: 10.1002/bjs.11372.
    >> Share

    October 2019
  105. DEN BAKKER CM, Anema JR, Huirne JAF, Twisk J, et al
    Predicting return to work among patients with colorectal cancer.
    Br J Surg. 2019 Oct 25. doi: 10.1002/bjs.11313.
    >> Share

  106. ZABOROWSKI A, Stakelum A, Winter DC
    Author response to: Total neoadjuvant therapy in rectal cancer-improvement or overtreatment?
    Br J Surg. 2019;106:1558.
    >> Share

  107. MROCZKOWSKI P, Dziki L
    Total neoadjuvant therapy in rectal cancer - improvement or overtreatment?
    Br J Surg. 2019;106:1558.
    >> Share

    August 2019
  108. GARLIPP B, Gibbs P, Van Hazel GA, Jeyarajah R, et al
    Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trial.
    Br J Surg. 2019 Aug 19. doi: 10.1002/bjs.11283.
    >> Share

  109. LARSEN SG, Pfeffer F, Korner H
    Norwegian moratorium on transanal total mesorectal excision.
    Br J Surg. 2019;106:1120-1121.
    >> Share

  110. PUCCIARELLI S, Del Bianco P, Pace U, Bianco F, et al
    Multicentre randomized clinical trial of colonic J pouch or straight stapled colorectal reconstruction after low anterior resection for rectal cancer.
    Br J Surg. 2019;106:1147-1155.
    >> Share

  111. ERLANDSSON J, Pettersson D, Glimelius B, Holm T, et al
    Postoperative complications in relation to overall treatment time in patients with rectal cancer receiving neoadjuvant radiotherapy.
    Br J Surg. 2019;106:1248-1256.
    >> Share

  112. BACHET JB, Moreno-Lopez N, Vigano L, Marchese U, et al
    BRAF mutation is not associated with an increased risk of recurrence in patients undergoing resection of colorectal liver metastases.
    Br J Surg. 2019;106:1237-1247.
    >> Share

    July 2019
  113. ROTTIER SJ, van Dijk ST, van Geloven AAW, Schreurs WH, et al
    Meta-analysis of the role of colonoscopy after an episode of left-sided acute diverticulitis.
    Br J Surg. 2019;106:988-997.
    >> Share

  114. LAKKIS Z, Vernerey D, Mege D, Faucheron JL, et al
    Morbidity and oncological outcomes of rectal cancer impaired by previous prostate malignancy.
    Br J Surg. 2019;106:1087-1098.
    >> Share

  115. ZABOROWSKI A, Stakelum A, Winter DC
    Systematic review of outcomes after total neoadjuvant therapy for locally advanced rectal cancer.
    Br J Surg. 2019;106:979-987.
    >> Share

  116. AMELUNG FJ, Borstlap WAA, Consten ECJ, Veld JV, et al
    Propensity score-matched analysis of oncological outcome between stent as bridge to surgery and emergency resection in patients with malignant left-sided colonic obstruction.
    Br J Surg. 2019;106:1075-1086.
    >> Share

    June 2019
  117. BEDNARSKI BK, Nickerson TP, You YN, Messick CA, et al
    Randomized clinical trial of accelerated enhanced recovery after minimally invasive colorectal cancer surgery (RecoverMI trial).
    Br J Surg. 2019 Jun 19. doi: 10.1002/bjs.11223.
    >> Share

  118. SILLO TO, Beggs AD, Morton DG, Middleton G, et al
    Mechanisms of immunogenicity in colorectal cancer.
    Br J Surg. 2019 Jun 19. doi: 10.1002/bjs.11204.
    >> Share

  119. HAMID HKS
    Correspondence.
    Br J Surg. 2019;106:949-950.
    >> Share

  120. DUCHALAIS E, Larson DW
    Correspondence.
    Br J Surg. 2019;106:950-951.
    >> Share


  121. Snapshot quiz.
    Br J Surg. 2019;106:836.
    >> Share

  122. QUIRAM BJ, Crippa J, Grass F, Lovely JK, et al
    Impact of enhanced recovery on oncological outcomes following minimally invasive surgery for rectal cancer.
    Br J Surg. 2019;106:922-929.
    >> Share

    May 2019
  123. SHINKINS B, Primrose JN, Pugh SA, Nicholson BD, et al
    Serum carcinoembryonic antigen trends for diagnosing colorectal cancer recurrence in the FACS randomized clinical trial.
    Br J Surg. 2019;106:728.
    >> Share

  124. WESTBERG K, Palmer G, Hjern F, Holm T, et al
    Population-based study of surgical treatment with and without tumour resection in patients with locally recurrent rectal cancer.
    Br J Surg. 2019;106:790-798.
    >> Share

  125. VAN DER POEL MJ, Barkhatov L, Fuks D, Berardi G, et al
    Multicentre propensity score-matched study of laparoscopic versus open repeat liver resection for colorectal liver metastases.
    Br J Surg. 2019;106:783-789.
    >> Share

    April 2019
  126. REYNOLDS IS, Furney SJ, Kay EW, McNamara DA, et al
    Meta-analysis of the molecular associations of mucinous colorectal cancer.
    Br J Surg. 2019 Apr 4. doi: 10.1002/bjs.11142.
    >> Share

  127. KEANE C, Park J, Oberg S, Wedin A, et al
    Functional outcomes from a randomized trial of early closure of temporary ileostomy after rectal excision for cancer.
    Br J Surg. 2019;106:645-652.
    >> Share

    March 2019
  128. ABIS GSA, Stockmann HBAC, Bonjer HJ, van Veenendaal N, et al
    Randomized clinical trial of selective decontamination of the digestive tract in elective colorectal cancer surgery (SELECT trial).
    Br J Surg. 2019;106:355-363.
    >> Share


  129. Snapshot quiz.
    Br J Surg. 2019;106:341.
    >> Share

  130. KELLER DS, Reali C, Spinelli A, Penna M, et al
    Patient-reported functional and quality-of-life outcomes after transanal total mesorectal excision.
    Br J Surg. 2019;106:364-366.
    >> Share

  131. LAU YC, Jongerius K, Wakeman C, Heriot AG, et al
    Influence of the level of sacrectomy on survival in patients with locally advanced and recurrent rectal cancer.
    Br J Surg. 2019;106:484-490.
    >> Share

  132. VAN 'T SANT I, van Eden WJ, Engbersen MP, Kok NFM, et al
    Diffusion-weighted MRI assessment of the peritoneal cancer index before cytoreductive surgery.
    Br J Surg. 2019;106:491-498.
    >> Share

  133. AHL R, Matthiessen P, Fang X, Cao Y, et al
    Effect of beta-blocker therapy on early mortality after emergency colonic cancer surgery.
    Br J Surg. 2019;106:477-483.
    >> Share

    February 2019
  134. SEGELMAN J, Buchli C, Svanstrom Rojvall A, Matthiessen P, et al
    Effect of radiotherapy for rectal cancer on ovarian androgen production.
    Br J Surg. 2019;106:267-275.
    >> Share

    January 2019
  135. BJORNELV GMW, Dueland S, Line PD, Joranger P, et al
    Cost-effectiveness of liver transplantation in patients with colorectal metastases confined to the liver.
    Br J Surg. 2019;106:132-141.
    >> Share

  136. ELFEKI H, Larsen HM, Emmertsen KJ, Christensen P, et al
    Bowel dysfunction after sigmoid resection for cancer and its impact on quality of life.
    Br J Surg. 2019;106:142-151.
    >> Share

    November 2018
  137. KOSKENVUO L, Malila N, Pitkaniemi J, Miettinen J, et al
    Sex differences in faecal occult blood test screening for colorectal cancer.
    Br J Surg. 2018 Nov 21. doi: 10.1002/bjs.11011.
    >> Share

    August 2018
  138. BARE M, Mora L, Tora N, Gil MJ, et al
    CCR-CARESS score for predicting operative mortality in patients with colorectal cancer.
    Br J Surg. 2018 Aug 13. doi: 10.1002/bjs.10956.
    >> Share

  139. MARGONIS GA, Sasaki K, Gholami S, Kim Y, et al
    Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases.
    Br J Surg. 2018;105:1210-1220.
    >> Share

  140. OKUNO M, Goumard C, Mizuno T, Kopetz S, et al
    Prognostic impact of perihepatic lymph node metastases in patients with resectable colorectal liver metastases.
    Br J Surg. 2018;105:1200-1209.
    >> Share

    May 2018

  141. Advanced colorectal cancer issue.
    Br J Surg. 2018;105:E240-E247.
    >> Share

  142. BROWN KGM, Solomon MJ
    Progress and future direction in the management of advanced colorectal cancer.
    Br J Surg. 2018;105:615-617.
    >> Share

  143. PASSOT G, Dumont F, Goere D, Arvieux C, et al
    Multicentre study of laparoscopic or open assessment of the peritoneal cancer index (BIG-RENAPE).
    Br J Surg. 2018;105:663-667.
    >> Share

  144. YAMASHITA S, Chun YS, Kopetz SE, Vauthey JN, et al
    Biomarkers in colorectal liver metastases.
    Br J Surg. 2018;105:618-627.
    >> Share


  145. Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer.
    Br J Surg. 2018;105:650-657.
    >> Share

    April 2018
  146. QUYN AJ, Fraser CG, Rodger J, Digan A, et al
    Participation in bowel screening among men attending abdominal aortic aneurysm screening.
    Br J Surg. 2018;105:529-534.
    >> Share

    March 2018
  147. SHINKINS B, Primrose JN, Pugh SA, Nicholson BD, et al
    Serum carcinoembryonic antigen trends for diagnosing colorectal cancer recurrence in the FACS randomized clinical trial.
    Br J Surg. 2018 Mar 26. doi: 10.1002/bjs.10819.
    >> Share

  148. DUELAND S, Foss A, Solheim JM, Hagness M, et al
    Survival following liver transplantation for liver-only colorectal metastases compared with hepatocellular carcinoma.
    Br J Surg. 2018 Mar 13. doi: 10.1002/bjs.10769.
    >> Share

  149. VAN ZOGGEL DMGI, Bosman SJ, Kusters M, Nieuwenhuijzen GAP, et al
    Preliminary results of a cohort study of induction chemotherapy-based treatment for locally recurrent rectal cancer.
    Br J Surg. 2018;105:447-452.
    >> Share

    February 2018
  150. PARK J, Danielsen AK, Angenete E, Bock D, et al
    Quality of life in a randomized trial of early closure of temporary ileostomy after rectal resection for cancer (EASY trial).
    Br J Surg. 2018;105:244-251.
    >> Share

  151. GRUT H, Solberg S, Seierstad T, Revheim ME, et al
    Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases.
    Br J Surg. 2018;105:295-301.
    >> Share

    January 2018
  152. ESCAL L, Nougaret S, Guiu B, Bertrand MM, et al
    MRI-based score to predict surgical difficulty in patients with rectal cancer.
    Br J Surg. 2018;105:140-146.
    >> Share

  153. UBINK I, van Eden WJ, Snaebjornsson P, Kok NFM, et al
    Histopathological and molecular classification of colorectal cancer and corresponding peritoneal metastases.
    Br J Surg. 2018;105:e204-e211.
    >> Share

  154. MARKS KM, West NP, Morris E, Quirke P, et al
    Clinicopathological, genomic and immunological factors in colorectal cancer prognosis.
    Br J Surg. 2018;105:e99-e109.
    >> Share

  155. RYAN EJ, Creagh EM
    Emerging methods in colorectal cancer screening.
    Br J Surg. 2018;105:e16-e18.
    >> Share

  156. GAINES S, Shao C, Hyman N, Alverdy JC, et al
    Gut microbiome influences on anastomotic leak and recurrence rates following colorectal cancer surgery.
    Br J Surg. 2018;105:e131-e141.
    >> Share

  157. KOYAMA FC, Lopes Ramos CM, Ledesma F, Alves VAF, et al
    Effect of Akt activation and experimental pharmacological inhibition on responses to neoadjuvant chemoradiotherapy in rectal cancer.
    Br J Surg. 2018;105:e192-e203.
    >> Share

    December 2017
  158. WESTBERG K, Palmer G, Hjern F, Nordenvall C, et al
    Population-based study of factors predicting treatment intention in patients with locally recurrent rectal cancer.
    Br J Surg. 2017;104:1866-1873.
    >> Share

    November 2017
  159. CREAVIN B, Kelly ME, Ryan E, Winter DC, et al
    Meta-analysis of the impact of surgical approach on the grade of mesorectal excision in rectal cancer.
    Br J Surg. 2017;104:1609-1619.
    >> Share

  160. DIEDEREN K, Sahami SS, Tabbers MM, Benninga MA, et al
    Outcome after restorative proctocolectomy and ileal pouch-anal anastomosis in children and adults.
    Br J Surg. 2017;104:1640-1647.
    >> Share

    October 2017
  161. NITSCHE U, Stoss C, Stecher L, Wilhelm D, et al
    Meta-analysis of outcomes following resection of the primary tumour in patients presenting with metastatic colorectal cancer.
    Br J Surg. 2017 Oct 31. doi: 10.1002/bjs.10682.
    >> Share

  162. ELLEBAEK SB, Fristrup CW, Hovendal C, Qvist N, et al
    Randomized clinical trial of laparoscopic ultrasonography before laparoscopic colorectal cancer resection.
    Br J Surg. 2017;104:1462-1469.
    >> Share

    February 2017
  163. MARTLING A, Smedby KE, Birgisson H, Olsson H, et al
    Risk of second primary cancer in patients treated with radiotherapy for rectal cancer.
    Br J Surg. 2017;104:278-287.
    >> Share

  164. HAIN E, Maggiori L, Manceau G, Mongin C, et al
    Oncological impact of anastomotic leakage after laparoscopic mesorectal excision.
    Br J Surg. 2017;104:288-295.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016